Xencor
465 North Halstead Street, Suite 200
Pasadena
California
91107
United States
Tel: 626-305-5900
Website: http://www.xencor.com/
332 articles about Xencor
-
Xencor To Host Fourth Quarter And Full Year 2014 Financial Results Webcast And Conference Call
2/12/2015
-
Xencor To Webcast Presentations At Two Upcoming Conferences In February
2/5/2015
-
XencorReports XmAb®7195 Top-line Interim Phase 1a Results Showing Rapid Reduction Of Serum Ige In Healthy Volunteers
1/29/2015
-
Xencor Reports Top-line XmAb®5871 Phase 1b/2a Results Showing Promising Clinical Activity In Rheumatoid Arthritis
1/29/2015
-
SoCal's Xencor Snags $175 Million+ R&D Pact With Novo Nordisk A/S
12/18/2014
-
MorphoSys AG And Xencor Publish Final Results From Phase 1/2a Trial Of MOR208 (Xmab5574) In CLL/SLL At Xencor Annual Meeting
12/8/2014
-
Xencor To Present At The 25th Annual Oppenheimer Healthcare Conference
12/5/2014
-
Xencor To Present At The 2014 Deutsche Bank BioFEST Conference
11/25/2014
-
Xencor Reports Third Quarter 2014 Financial Results
11/11/2014
-
Xencor Provides Data Updates On XmAb Bispecific Antibody Programs And Announces Presentations At Upcoming American Society of Hematology 2014 Annual Meeting
11/6/2014
-
Xencor To Present At The 2014 Credit Suisse Annual Healthcare Conference
11/4/2014
-
Xencor To Host Third Quarter 2014 Financial Results Webcast And Conference Call
11/3/2014
-
Xencor Regains All Rights From Amgen To Rare AutoImmune Disease Drug, Dumps Arthritis Hopes
10/29/2014
-
Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development And Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel
9/3/2014
-
Xencor To Present At Wedbush Securities 2014 Life Sciences Management Access Conference
8/5/2014
-
Xencor Reports Second Quarter 2014 Financial Results
8/1/2014
-
Xencor To Host Second Quarter 2014 Financial Results Webcast And Conference Call
7/24/2014
-
Xencor Appoints Kurt Gustafson To Board Of Directors; Promotes John Desjarlais To Chief Scientific Officer
7/15/2014
-
Xencor Initiates Phase 1 Study Of XmAb7195 For Asthma
5/28/2014
-
Xencor To Present At Jefferies and Co. 2014 Global Healthcare Conference
5/22/2014